Letosteine
![]() | |
| Clinical data | |
|---|---|
| Trade names | Viscotiol |
| Routes of administration | Oral (gastroresistant capsules) |
| ATC code | R05CB09 (WHO) |
| Identifiers | |
| |
| Synonyms | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
| CAS Number |
53943-88-7 |
| PubChem (CID) | 68707 |
| DrugBank |
DB08939 |
| ChemSpider |
61958 |
| UNII |
6MVF9U95DW |
| KEGG |
D07380 |
| ChEBI |
CHEBI:88271 |
| ECHA InfoCard | 100.053.509 |
| Chemical and physical data | |
| Formula | C10H17NO4S2 |
| Molar mass | 279.378 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.[1] He filed his application in 2000.
References
This article is issued from Wikipedia - version of the 8/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
